NCT03575260View on ClinicalTrials.gov

500mg Fulvestrant Versus Exemestane in MBC

CompletedOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

January 10, 2019

Study Completion Date

January 15, 2019

Conditions

Breast Cancer

Trial Locations (1)

200032

Biyun Wang, MD, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER

NCT03575260 - 500mg Fulvestrant Versus Exemestane in MBC | Biotech Hunter | Biotech Hunter